Synergizing radiotherapy and immunotherapy: Current challenges and strategies for optimization

por Rajeev-Kumar, Greeshma, Pitroda, Sean P.
Publicado 2022

microRNAs and oligometastasis

por Khodarev, Nikolai N., Pitroda, Sean P., Weichselbaum, Ralph R.
Publicado 2015

Oligometastatic prostate cancer: Reality or figment of imagination?

por Foster, Corey C., Weichselbaum, Ralph R., Pitroda, Sean P.
Publicado 2018

Treatment of Cancer with Radio-Immunotherapy: What We Currently Know and What the Future May Hold

por Turchan, William Tyler, Pitroda, Sean P., Weichselbaum, Ralph R.
Publicado 2021

Combined radio-immunotherapy: An opportunity to increase the therapeutic ratio of oligometastasis-directed radiotherapy

por Turchan, William Tyler, Pitroda, Sean P., Weichselbaum, Ralph R.
Publicado 2022

[(Di-o-tolyl­phosphino)meth­yl]diphenyl­phosphine sulfide

por Pitroda, Priyanka P., Badgett, Ansonia H., Dickey, Geralyn A., Gray, Danielle L., Shelby, Quinetta D.
Publicado 2009

STAT1-dependent expression of energy metabolic pathways links tumour growth and radioresistance to the Warburg effect

por Pitroda, Sean P, Wakim, Bassam T, Sood, Ravi F, Beveridge, Mara G, Beckett, Michael A, MacDermed, Dhara M, Weichselbaum, Ralph R, Khodarev, Nikolai N
Publicado 2009

MUC1-associated proliferation signature predicts outcomes in lung adenocarcinoma patients

por MacDermed, Dhara M, Khodarev, Nikolai N, Pitroda, Sean P, Edwards, Darrin C, Pelizzari, Charles A, Huang, Lei, Kufe, Donald W, Weichselbaum, Ralph R
Publicado 2010

Radioresistance of Stat1 over-expressing tumour cells is associated with suppressed apoptotic response to cytotoxic agents and increased IL6-IL8 signalling

por Efimova, Elena V., Liang, Hua, Pitroda, Sean P., Labay, Edwardine, Darga, Thomas E., Levina, Vera, Lokshin, Anna, Roizman, Bernard, Weichselbaum, Ralph R., Khodarev, Nikolai N.
Publicado 2009

Oncogenic CXCL10 signalling drives metastasis development and poor clinical outcome

por Wightman, S C, Uppal, A, Pitroda, S P, Ganai, S, Burnette, B, Stack, M, Oshima, G, Khan, S, Huang, X, Posner, M C, Weichselbaum, R R, Khodarev, N N
Publicado 2015

Imaging of tumor clones with differential liver colonization

por Oshima, Go, Wightman, Sean C., Uppal, Abhineet, Stack, Melinda E., Pitroda, Sean P., Oskvarek, Jonathan J., Huang, Xiaona, Posner, Mitchell C., Hellman, Samuel, Weichselbaum, Ralph R., Khodarev, Nikolai N.
Publicado 2015

Suppression of local type I interferon by gut microbiota–derived butyrate impairs antitumor effects of ionizing radiation

por Yang, Kaiting, Hou, Yuzhu, Zhang, Yuan, Liang, Hua, Sharma, Anukriti, Zheng, Wenxin, Wang, Liangliang, Torres, Rolando, Tatebe, Ken, Chmura, Steven J., Pitroda, Sean P., Gilbert, Jack A., Fu, Yang-Xin, Weichselbaum, Ralph R.
Publicado 2021

Cancer therapies activate RIG-I-like receptor pathway through endogenous non-coding RNAs

por Ranoa, Diana Rose E., Parekh, Akash D., Pitroda, Sean P., Huang, Xiaona, Darga, Thomas, Wong, Anthony C., Huang, Lei, Andrade, Jorge, Staley, Jonathan P., Satoh, Takashi, Akira, Shizuo, Weichselbaum, Ralph R., Khodarev, Nikolai N.
Publicado 2016

STAT1 Pathway Mediates Amplification of Metastatic Potential and Resistance to Therapy

por Khodarev, Nikolai N., Roach, Paul, Pitroda, Sean P., Golden, Daniel W., Bhayani, Mihir, Shao, Michael Y., Darga, Thomas E., Beveridge, Mara G., Sood, Ravi F., Sutton, Harold G., Beckett, Michael A., Mauceri, Helena J., Posner, Mitchell C., Weichselbaum, Ralph R.
Publicado 2009

Tumor Endothelial Inflammation Predicts Clinical Outcome in Diverse Human Cancers

por Pitroda, Sean P., Zhou, Tong, Sweis, Randy F., Filippo, Matthew, Labay, Edwardine, Beckett, Michael A., Mauceri, Helena J., Liang, Hua, Darga, Thomas E., Perakis, Samantha, Khan, Sajid A., Sutton, Harold G., Zhang, Wei, Khodarev, Nikolai N., Garcia, Joe G. N., Weichselbaum, Ralph R.
Publicado 2012

14q32-encoded microRNAs mediate an oligometastatic phenotype

por Uppal, Abhineet, Wightman, Sean C., Mallon, Stephen, Oshima, Go, Pitroda, Sean P., Zhang, Qingbei, Huang, Xiaona, Darga, Thomas E., Huang, Lei, Andrade, Jorge, Liu, Huiping, Ferguson, Mark K., Greene, Geoffrey L., Posner, Mitchell C., Hellman, Samuel, Khodarev, Nikolai N., Weichselbaum, Ralph R.
Publicado 2015

Basal Tumor Cell Isolation and Patient-Derived Xenograft Engraftment Identify High-Risk Clinical Bladder Cancers

por Skowron, K. B., Pitroda, S. P., Namm, J. P., Balogun, O., Beckett, M. A., Zenner, M. L., Fayanju, O., Huang, X., Fernandez, C., Zheng, W., Qiao, G., Chin, R., Kron, S. J., Khodarev, N. N., Posner, M. C., Steinberg, G. D., Weichselbaum, R. R.
Publicado 2016

A proliferative subtype of colorectal liver metastases exhibits hypersensitivity to cytotoxic chemotherapy

por Spurr, Liam F., Martinez, Carlos A., Katipally, Rohan R., Iyer, Soumya C., Pugh, Sian A., Bridgewater, John A., Primrose, John N., Domingo, Enric, Maughan, Timothy S., D’Angelica, Michael I., Talamonti, Mark, Posner, Mitchell C., Connell, Philip P., Weichselbaum, Ralph R., Pitroda, Sean P.
Publicado 2022

Integrated molecular subtyping defines a curable oligometastatic state in colorectal liver metastasis

por Pitroda, Sean P., Khodarev, Nikolai N., Huang, Lei, Uppal, Abhineet, Wightman, Sean C., Ganai, Sabha, Joseph, Nora, Pitt, Jason, Brown, Miguel, Forde, Martin, Mangold, Kathy, Xue, Lai, Weber, Christopher, Segal, Jeremy P., Kadri, Sabah, Stack, Melinda E., Khan, Sajid, Paty, Philip, Kaul, Karen, Andrade, Jorge, White, Kevin P., Talamonti, Mark, Posner, Mitchell C., Hellman, Samuel, Weichselbaum, Ralph R.
Publicado 2018

Author Correction: Integrated molecular subtyping defines a curable oligometastatic state in colorectal liver metastasis

por Pitroda, Sean P., Khodarev, Nikolai N., Huang, Lei, Uppal, Abhineet, Wightman, Sean C., Ganai, Sabha, Joseph, Nora, Pitt, Jason, Brown, Miguel, Forde, Martin, Mangold, Kathy, Xue, Lai, Weber, Christopher, Segal, Jeremy P., Kadri, Sabah, Stack, Melinda E., Khan, Sajid, Paty, Philip, Kaul, Karen, Andrade, Jorge, White, Kevin P., Talamonti, Mark, Posner, Mitchell C., Hellman, Samuel, Weichselbaum, Ralph R.
Publicado 2018